Christopher Thomas Scott

Administrative Appointments

• Stem Cell Research Advisory Panel, Stanford University , (2007– 2009 )
• Director, Program on Stem Cells in Society, Stanford Center for Biomedical Ethics , (2006– present )
• Course Director, The Stem Cell, Program on Continuing Studies , (2005– present )
• Course Director, Stem Cell Biology, Program in Human Biology , (2006– 2008 )
• Assistant Vice Chancellor, University of California, San Francisco , (2000– 2002 )
• Executive Director, ACCESS Clinical Trials, Stanford Medical Center , (1996– 1997 )
• Director, Research Development, Stanford University Medical Center , (1998– 2000 )
• Associate Director, Beckman Center for Molecular Medicine, Stanford University School of Medicine , (1992– 1998 )
• Director, Corporate Development, Stanford University School of Medicine , (1994– 1996 )
• Associate Director, Program on Molecular and Genetic Medicine, Stanford University School of Medicine , (1994– 1999 )
• Institutional Review Board (non voting), Stanford University , (1998– 2000 )
• Founder, UCSF Center for Bioentrepreneurship, University of California, San Francisco , (2000– 2002 )

Honors and Awards

• Knight Fellows Favorite Professor Award, Knight Fellows Program, Stanford (2006,2008)
• Marsh O'Neill Award (Contributions to Stanford's research enterprise), Stanford University (1999)

Professional Education

• MA, Stanford University Policy, Liberal Arts
• BA; BS, Colorado University Biological Sciences

Community & International Work

• The Stem Cell Advisors, Palo Alto, California More »
• International Society of Stem Cell Research, Boston, MA More »

Research Interests

The PSCS Areas of Scholarly Concentration

1) Study the political, legal, ethical, technological and economic impacts of stem cell research.
2) Educate undergraduate and graduate students and provide outreach to secondary schools and the general public about stem cell research.
3) Serve as a resource for academicians, public officials and the public on the scientific, legal and ethical impacts of stem cell research.

Outcomes

1. Present papers and talks at national and international conferences.
2. Publish peer reviewed research in top ranked journals.
3. Teach and guide the development of secondary and higher education curricula.
4. Serve as resource for the public and government officials through consultations and committee memberships.

Accomplishments

• Publication of peer-reviewed articles, essays and papers in internationally recognized journals such as Nature, Science, and Cell Stem Cell.
• Participation on state and national stem cell advisory boards, committees and in national and international conferences
• Release of a popular science book, Stem Cell Now (Plume, 2007), on the scientific, ethical and political dimensions of stem cell research
• Develop classes in stem cell biology, ethics and policy for Stanford students, Stanford Continuing Education
• Participate in high school programs on stem cell biology
• Featured appearances and recurring coverage in local, national and international news media
• Hold a lecture series and annual public symposium.

Publications

• Stem Cell Research Policy and iPS Cells Timothy Caulfield,  Christopher Scott, Insoo Hyun, Robin Lovell-Badge, Kato Kazuto, Amy Zarzeczny.  Nature Medicine.  2009; In Press
• The Practical Consequences of a National Human Embryonic Stem Cell Registry. Taymor K,  Scott CT.  Stem Cell Rev Rep.  2009;
• Gilead's deal of a lifetime. Huggett B,  Scott C.  Nat Biotechnol.  2009; 27 (5): 423
• We must reverse the Bush legacy of stem-cell problems. Thomas Scott C,  Owen-Smith J, McCormick J.  Nature.  2009; 460 (7251): 33
• And then there were two: use of hESC lines. Scott CT,  McCormick JB, Owen-Smith J.  Nat Biotechnol.  2009; 27 (8): 696-7
• iPS Cells: Mapping the Policy Issues Amy Zarzcezny,  Christopher Scott , Insoo Hyun , Jami Bennett , Jennifer Chandler , Sophie Chargé , Heather Heine , Rosario Isasi , Kazuto Kato , Robin Lovell-Badge , Kelly McNagny , Duanqing Pei , Janet Rossant , Azim Surani , Patrick L. Taylor , Ubaka Ogbogu , Timothy Caulfield.  Cell.  2009; In Press
• Stem cell transplants: the power of peer-to-peer. Creasy G,  Scott CT.  Nat Biotechnol.  2009; 27 (1): 21-2
• Distribution of human embryonic stem cell lines: who, when, and where. McCormick JB,  Owen-Smith J, Scott CT.  Cell Stem Cell.  2009; 4 (2): 107-10
• The stem-cell century a new epoch and fresh challenges. McCormick JB,  Scott CT.  Perspect Biol Med.  2009; 52 (1): 126-33
• Hochschullehrerprivileg: A Modern Incarnation of the Professor’s Privilege to Promote University to Industry Technology Transfer Greenbaum, D,  Scott, CT.  Science, Technology, and Society.  2009; 14 (1): (in press)
• Ethics report on interspecies somatic cell nuclear transfer research. Skene L,  Testa G, Hyun I, Jung KW, McNab A, Robertson J, Scott CT, Solbakk JH, Taylor P, Zoloth L.  Cell Stem Cell.  2009; 5 (1): 27-30
• The road to pluripotence: the research response to the embryonic stem cell debate. Scott CT,  Reijo Pera RA.  Hum Mol Genet.  2008; 17 (R1): R3-9
• Weighing Risks and Rewards en route to the Clinic Scott, CT,  Nature Reports Stem Cells (DOI: 10.1038/stemcells.2008.158).  2008;
• What Stem Cell Therapy Can Learn From Gene Therapy. Scott, CT,  Nature Reports Stem Cells (DOI: 10.1038/stemcells.2008.123).  2008;
• Patenting pluripotence: the next battle for stem cell intellectual property. Vrtovec KT,  Scott CT.  Nat Biotechnol.  2008; 26 (4): 393-5
• Cloning Scott, CT,  Weissman, IR.  “From Assisted Reproduction to Stem Cells: The Hastings Center Bioethics Briefing Book.  2008; 24-29
• Challenges to human embryonic stem cell patents. Plomer A,  Taymor KS, Scott CT.  Cell Stem Cell.  2008; 2 (1): 13-7
• Stem cells: new frontiers of ethics, law, and policy. Scott CT,  Neurosurg Focus.  2008; 24 (3-4): E24
• Private Stem Cell Bank is a Poor Investment Scott, CT,  Chiao, E.  San Francisco Chronicle.  2007; August 31 (op/ed)
• State Stem Cell Program Facing Tough Times Ahead Scott, CT,  Sacramento Bee.  2007; August 31 (op/ed)
• Mice with a human touch. Scott CT,  Nat Biotechnol.  2007; 25 (10): 1075-7
• Overhauling clinical trials. Scott CT,  Baker M.  Nat Biotechnol.  2007; 25 (3): 287-92
• Splitting the Difference Christopher Thomas Scott,  Science and Spirit.  2007; 18 (2): 38-41
• Chimeras in the crosshairs. Scott CT,  Nat Biotechnol.  2006; 24 (5): 487-90
• The Future of Medicine Christopher Thomas Scott,  Old Trout.  2006; 1 (3): 21
• Patient advocacy encourages stem-cell research Christopher Thomas Scott,  San Jose Mercury News.  2006; August 8
• It is Better to Give Christopher Thomas Scott,  The New Scientist.  2006; 25 (2531): 25
• The paths around stem cell intellectual property. Taymor KS,  Scott CT, Greely HT.  Nat Biotechnol.  2006; 24 (4): 411-3
• Falling Behind on Stem Cell Research Christopher Thomas Scott,  Jennifer McCormick.  Boston Globe.  2006; op/ed (April 28)
• Stem Cell Now: A brief introduction to the coming medical revolution Christopher Thomas Scott,  Penguin/Plume, New York: ISBN: 0-13-173798-8.  2006;
• Stand by Science Christopher Thomas Scott,  Edutopia.  2005; 1 (4): 52-54
• Stem Cell Hub to Link Three Continents Christopher Thomas Scott,  Nat Biotechnol.  2005; 23 (1129): 1129
• Trials of the Heart: Hematopoeitic Stem Cells Enter the Clinic Christopher Thomas Scott,  The Scientist.  2005; July 4 20-21
• The problem with potency. Scott CT,  Nat Biotechnol.  2005; 23 (9): 1037-9
• Chasing a cellular fountain of youth. Wilan KH,  Scott CT, Herrera S.  Nat Biotechnol.  2005; 23 (7): 807-15
• The zinc finger nuclease monopoly. Scott CT,  Nat Biotechnol.  2005; 23 (8): 915-8